3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
1
Plasmacytoma
1
Neoplasm Metastasis
1
Homologous Recombination Deficient Solid Tumors
1
Drug-Related Side Effects and Adverse Reactions
1
Colonic Neoplasms
1
Interventions
Fluorouracil
19
Oxaliplatin
17
Capecitabine
16
Leucovorin
14
Cisplatin
12
Irinotecan
11
Gemcitabine
11
Drug Therapy
11
Bevacizumab
10
pembrolizumab
9
Radiosurgery
9
Cetuximab
9
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
Drug Combinations
×
Clear all
NCT04138381
2023-03-27
SeliGIST
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
Unknown
30 enrolled